Obscurin deficiency leads to compensated dilated cardiomyopathy and increased arrhythmias is a research paper published in The Journal of General Physiology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Recovery and Resilience Plan
Grant: 1.4 CUP B63C22000610006
National Recovery and Resilience Plan
Grant: 1.5 CUP B63C22000680007
National Institutes of Health
Grant: HL152251
National Institutes of Health
Grant: HL128457
Novo Nordisk Fonden
Grant: NNF22OC0079368
Aarhus Universitets Forskningsfond
Grant: AUFF-E-2022-7-9
Lundbeck Foundation
Grant: R396-2022-189
Independent Research Fund Denmark
Grant: #3165-00028B
NHLBI NIH HHS
Grant: R01 HL128457
NHLBI NIH HHS
Grant: R01 HL152251
National Institutes of Health
Grant: 1R01HL152251-01A1
The role of obscurin and Obsl1 as key determinants for diastolic function
Independent Research Fund Denmark
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL128457-05
Signaling Pathways in Dilated Cardiomyopathy
Tuscan Health Ecosystem
Center for Gene Therapy and Drugs Based on RNA Technology
Next Generation European Union
Next Generation European Union
Center for Gene Therapy and Drugs Based on RNA Technology
Tuscan Health Ecosystem
FWCI
0.76
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals